Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Collexa
- Development stage
- Unknown
- Lead developer
- Innocoll
- Administration
- Topical
01
Overview
Collexa is an approved collagen-based pharmaceutical product and medical device developed and commercialized by Innocoll AG. It functions as an advanced bilayer wound dressing, comprising a collagen matrix sponge with a polyurethane foam backing. This product is indicated for the management of various types of wounds, including heavily exudating chronic wounds, burns, diabetic ulcers, venous ulcers, pressure ulcers, traumatic wounds, and dehisced surgical wounds. The collagen component likely provides a scaffold for tissue regeneration, while the polyurethane foam backing aids in absorbing wound exudates.
- Brand names
- Collexa
Beyond the preview
Go deeper on Collexa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Collexa.